<DOC>
	<DOCNO>NCT00000267</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy risperidone cocaine dependence individual schizophrenia/schizoaffective illness .</brief_summary>
	<brief_title>Risperidone Treatment Dually-Diagnosed Individuals - 2</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Please contact site information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>